Latest Sustainable Investing News

Boom Logistics has upgraded its FY26 earnings guidance, anticipating a 31% rise in statutory EPS, backed by $7 million in new contracts across energy and mining sectors.

Neuren Pharmaceuticals reported a solid A$30.4 million net profit in 2025, powered by a 15% rise in DAYBUE® royalties. The company is progressing its NNZ-2591 Phase 3 trial for Phelan-McDermid syndrome and has initiated a share buy-back amid perceived undervaluation.

Locksley Resources has kicked off maiden diamond drilling at its Desert Antimony Mine and El Campo Rare Earth Element Prospect, alongside producing 99.5% purity antimony trioxide, reinforcing its push for a US domestic critical minerals supply chain.

PainChek Limited reported a half-year loss of AUD 4.7 million but achieved a major regulatory milestone with FDA clearance for its Adult App, unlocking significant US market opportunities. The company also completed a share consolidation and raised capital to support growth.

Etherstack plc reported a robust FY2025 financial rebound with revenue soaring 70% to US$10.1 million, driven by major US project deliveries and a 62% rise in recurring support revenues. The company also turned EBITDA positive and secured key long-term contracts, setting the stage for strong growth in 2026.

Regal Partners Limited reported a near doubling of net profit after tax to $130.5 million for 2025, alongside a 16% rise in funds under management to $20.9 billion. The company declared a fully franked 15 cent dividend and announced a $75 million on-market share buy-back program.

SGH Ltd reported a resilient first half of FY26 with stable earnings, improved margins, and a significant boost in operating cash flow, underpinning a 7% rise in its interim dividend.

PYC Therapeutics has initiated a substantial capital raising effort, aiming to secure up to A$653 million to propel its four RNA therapeutic candidates through critical clinical milestones. The retail entitlement offer opens today, following a successful institutional placement.

Orthocell Ltd reports steady progress in commercialising its nerve repair product Remplir in the US, with sales growth, expanded distributor networks, and manufacturing upgrades underpinning its path to profitability.

Dubber Corporation Limited has signed a significant five-year contract with a major North American communications provider, while trimming costs and targeting operating cashflow breakeven in FY26.

WA1 Resources reports exceptional assay results from the Luni Niobium Project alongside significant pre-development progress and government recognition as a Major Project.

Australian Ethical reported a slight 1% decline in funds under management to $14.08 billion for December 2025, balancing positive retail flows against institutional mandate losses and market headwinds.